Abstract #211 Table 1

Inclusion and exclusion criteria for title and abstract review

Inclusion Criteria	Exclusion Criteria
1. Papers from 1990 and later 2. English language 3. Published and peer reviewed 4. Contains empirical data 5. Human subjects study 6. Infants born before 37 weeks gestation 7. Postnatal GC exposure (exogenous) 8. GCs administered systemically - enteral, intravenous, intramuscular, inhaled, nebulized, intranasally administered, sublingual, or subcutaneous 9. GCs administered to infants during birth hospitalization 10. Reports on at least one structural brain outcome measured after postnatal GC exposure	1. Conference abstracts, case studies/reports if less than 10 subjects, dissertations; review papers; preprints; theoretical papers 2. Endogenous GC exposure 3. GCs only administered antenatally 4. No structural brain outcomes reported 6. Animal study with no human participants 7. Topical GC application only 8. GCs only after birth hospitalization discharge

Inclusion Criteria

Exclusion Criteria

1. Papers from 1990 and later
2. English language
3. Published and peer reviewed
4. Contains empirical data
5. Human subjects study
6. Infants born before 37 weeks gestation
7. Postnatal GC exposure (exogenous)
8. GCs administered systemically - enteral, intravenous, intramuscular, inhaled, nebulized, intranasally administered, sublingual, or subcutaneous
9. GCs administered to infants during birth hospitalization
10. Reports on at least one structural brain outcome measured after postnatal GC exposure

1. Conference abstracts, case studies/reports if less than 10 subjects, dissertations; review papers; preprints; theoretical papers
2. Endogenous GC exposure
3. GCs only administered antenatally
4. No structural brain outcomes reported
6. Animal study with no human participants
7. Topical GC application only
8. GCs only after birth hospitalization discharge